LAWRENCE A KENYON
CIK 1230484 · Chief Financial Officer · last filed 2024-09-30
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$176.2K
Companies
6
Total Filings
25
Lifetime Open-Market Net
-$460.8K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| OTLK | Chief Financial Officer | 5,946 | $1.22 | $7.3K | $28.4K | 2 | 2024-09-30 |
| Outlook Therapeutics, Inc. (OTLKW) Delisted | CEO, Pres, CFO, Treas & Secy | 18,926 | $0.03 | $568 | $36.1K | 9 | 2021-04-20 |
| Outlook Therapeutics, Inc. (ONSIW) Delisted | CEO, Pres, CFO, Treas & Secy | 57,213 | — | — | -$8.8K | 2 | 2018-09-18 |
| Outlook Therapeutics, Inc. (ONSIZ) Delisted | CFO and Secretary | 67,313 | — | — | -$29.6K | 2 | 2017-12-26 |
| PAR PHARMACEUTICAL COMPANIES, INC. (PRX) Delisted | EVP, Chief Financial Officer | 14,337 | — | — | -$540.4K | 6 | 2010-08-04 |
| ACEL | EVP, CFO and Secretary | 12,797 | $13.20 | $168.9K | $53.4K | 2 | 2007-04-12 |
Recent Filings · Page 2 of 3
25 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-02-08 | Outlook Therapeutics, Inc. (OTLKW) Delisted | Buy (P) | +25,000 | $22.4K | EDGAR |
| 2018-09-18 | Outlook Therapeutics, Inc. (ONSIW) Delisted | Sell (S) | −10,100 | -$8.8K | EDGAR |
| 2018-08-03 | Outlook Therapeutics, Inc. (ONSIW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-12-26 | Outlook Therapeutics, Inc. (ONSIZ) Delisted | Sell (S) | −26,165 | -$29.6K | EDGAR |
| 2016-12-22 | Outlook Therapeutics, Inc. (ONSIZ) Delisted | Grant (A) | +50,000 | $0 | EDGAR |
| 2014-02-26 | — | Grant (A) | — | $0 | |
| 2012-07-25 | — | Grant (A) | — | $0 | |
| 2010-08-04 | PAR PHARMACEUTICAL COMPANIES, INC. (PRX) Delisted | Tax (F) | −6,312 | -$169.8K | EDGAR |
| 2010-03-03 | PAR PHARMACEUTICAL COMPANIES, INC. (PRX) Delisted | Mixed | — | -$260.4K | EDGAR |
| 2010-01-12 | PAR PHARMACEUTICAL COMPANIES, INC. (PRX) Delisted | Tax (F) | −897 | -$23.2K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.